Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F H Bender

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Hospital Formulary|June 10, 1983
The P & T Committee Part 2: involvement by pharmacy, medical, and nursing personnelF H Bender
Hospital Formulary|April 11, 1983
The Pharmacy and Therapeutics Committee Part 1: overviewF H Bender
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 20, 1998
Successful treatment of severe hyponatremia in a patient with renal failure using continuous venovenous hemodialysisF H Bender
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1991
Polycythemia in diabetic patients on CAPDF H Bender, B Piraino
Hospital Formulary|September 8, 1983
Implementing and maintaining a viable formularyW N Kelly, F H Bender
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1996
Most nephrologists are primary care providers for chronic dialysis patients: results of a national surveyF H Bender, J L Holley
Hospital Formulary|July 9, 1984
Cost containment through P & T committee drug utilization reviewF H Bender, C S DeMatteo
Seminars in Psychiatry|February 1, 1970
Legal implications of the XYY syndromeD H Russell, F H Bender
Kidney International. Supplement|November 3, 2006
Prevention of infectious complications in peritoneal dialysis: best demonstrated practicesF H Bender, J Bernardini, B Piraino
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1992
Calcium mass transfer with dialysate containing 1.25 and 1.75 mmol/L calcium in peritoneal dialysis patientsF H Bender, J Bernardini, B Piraino
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Hospital Formulary|June 10, 1983
The P & T Committee Part 2: involvement by pharmacy, medical, and nursing personnelF H Bender
Hospital Formulary|April 11, 1983
The Pharmacy and Therapeutics Committee Part 1: overviewF H Bender
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 20, 1998
Successful treatment of severe hyponatremia in a patient with renal failure using continuous venovenous hemodialysisF H Bender
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1991
Polycythemia in diabetic patients on CAPDF H Bender, B Piraino
Hospital Formulary|September 8, 1983
Implementing and maintaining a viable formularyW N Kelly, F H Bender
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1996
Most nephrologists are primary care providers for chronic dialysis patients: results of a national surveyF H Bender, J L Holley
Hospital Formulary|July 9, 1984
Cost containment through P & T committee drug utilization reviewF H Bender, C S DeMatteo
Seminars in Psychiatry|February 1, 1970
Legal implications of the XYY syndromeD H Russell, F H Bender
Kidney International. Supplement|November 3, 2006
Prevention of infectious complications in peritoneal dialysis: best demonstrated practicesF H Bender, J Bernardini, B Piraino
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1992
Calcium mass transfer with dialysate containing 1.25 and 1.75 mmol/L calcium in peritoneal dialysis patientsF H Bender, J Bernardini, B Piraino
Pageof 2